US Stock MarketDetailed Quotes

ATNM Actinium

Watchlist
  • 1.470
  • +0.080+5.76%
Close Nov 21 16:00 ET
  • 1.470
  • 0.0000.00%
Post 16:20 ET
45.86MMarket Cap-1057P/E (TTM)

About Actinium Company

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.

Company Profile

SymbolATNM
Company NameActinium
Listing DateMar 26, 2014
Founded2000
CEOMr. Sandesh Seth
MarketAMEX
Employees49
Fiscal Year Ends12-31
Address100 Park Avenue,23rd floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-646-677-3870
Websitehttp://www.actiniumpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Sandesh Seth
  • Chairman of the Board and Chief Executive Officer
  • 4.70M
  • Steve O’Loughlin
  • Chief Financial Officer, Principal Accounting Officer, Corporate Secretary
  • 1.49M
  • Dr. June S. Almenoff, F.A.C.P.,M.D.,PhD
  • Director
  • --
  • Richard I. Steinhart
  • Independent Director
  • 313.00K
  • Dr. Ajit S. Shetty, PhD
  • Independent Director
  • 308.50K
  • Dr. Jeffrey W. Chell, M.D.
  • Independent Director
  • 301.00K
  • Dr. David Nicholson, Pd.D
  • Lead Independent Director
  • 313.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data